Our Panel

David Fields

Jason Few

Jack Stahl
July 31, 2025
Tariffs. AI. Geopolitics. Activists. Cybersecurity.
The list of risks firms must deal with in today’s business environment goes on and on. Literally. More than a few companies have filed annual reports with the SEC that contain risk factors to performance that run 20 pages or longer. And more risks keep popping up every day, as shareholders press firms on issues ranging from climate change to CEO succession to workforce planning, and everything in between. All of which has changed the game for the group that is ultimately most responsible for a firm’s future: the board. For at least some of them, risk management has taken on a whole new meaning. “Enterprise risk is no longer what it used to be,” says Elise Schroeter, global head for Korn Ferry’s organization and talent strategies for the Board and CEO practice. “It is so much more existential, unpredictable, and often incomprehensible nowadays.”
Directors are being more proactive in stress-testing management’s strategic plans, for instance, and developing contingency playbooks for dozens of different scenarios, from the pros and cons of building new domestic factories to deal with rising tariffs, to weighing whether the mounting costs of AI are worth it, to guarding against a cyberattack. While the number of boards featuring dedicated, stand-alone risk committees has remained relatively stable, boards are adding specific risk-oversight responsibilities to existing committees or ad hoc working groups that will dive deeper into the myriad risks facing companies.
Board directors themselves aren’t immune to risk, either. Activist investors have made priorities of director succession and board effectiveness, homing in on individual-director performance and weighing it against a host of factors such as age, tenure, experience, and skills. To be sure, board change now ranks above M&A as the top objective for activist campaigns. Board change has been the focus of more than half of all campaigns so far this year, well above the four-year average of 35 percent.
Against that backdrop, we decided to convene a panel of three impressive big-firm directors: Jason Few, the CEO and director at FuelCell Energy and a director on the board of Enbridge; David Fields, who serves on the boards of EastGroup Properties and CBL Properties; and finally, Jack Stahl, who is chairman of the board at United Natural Foods and a director at Catalent Pharma Solutions. They come from different industries—pharmaceuticals, real estate, clean energy—but the challenge for each to navigate today’s world remains similar. Below is a lightly edited version of our conversations.
